---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-027245"
form_type: "8-K"
ticker: "AARD"
cik: "0001774857"
company_name: "Aardvark Therapeutics, Inc."
filed_at: "2025-02-14T23:59:59+00:00"
generated_at: "2026-05-26T21:29:49.715512+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Aardvark Therapeutics completes IPO; issues 5.888M shares at $16.00, raises $94.2M gross

## Summary
- IPO of 5,888,000 shares at $16.00 per share completed on Feb 14, 2025.
- Gross proceeds $94.2M before underwriting discounts and commissions.
- Amended certificate authorizes 490M common shares and 10M preferred shares.
- Amended bylaws establish classified board, stockholder proposal procedures, and exclusive forum provision.
- Common stock trades on Nasdaq under ticker AARD.

## SEC filing metadata
- accession: 0001193125-25-027245
- form_type: 8-K
- ticker: AARD
- cik: 0001774857
- company_name: Aardvark Therapeutics, Inc.
- filed_at: 2025-02-14T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1774857/000119312525027245/0001193125-25-027245-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1774857/000119312525027245/d890894d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-027245
- JSON: https://secwatch.observer/filing/0001193125-25-027245.json
- Plain text: https://secwatch.observer/filing/0001193125-25-027245.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.